Patents Assigned to Transfert Plus
  • COMPOUND AND METHOD FOR REGULATING PLASMINOGEN ACTIVATION AND CELL MIGRATION
    Publication number: 20110243952
    Abstract: The invention relates to novel regulators of plasminogen activation and their use for regulating cell migration, plasminolysis, angiogenesis, fibrinolysis, for treating cancer and thrombo-embolic diseases such as heart stroke. Furthermore, the present invention relates to novel pharmaceutical compositions form regulating cell migration, plasminolysis, angiogenesis and for treating cancer. In particular, the present invention relates to a method of regulating the activation of plasminogen comprising contacting a solution of pro-urokinase (uPA) or tissue plasminogen activator (tPA) and plasminogen with melanotransferrin (p97) for a time sufficient to effect regulation thereof.
    Type: Application
    Filed: March 28, 2011
    Publication date: October 6, 2011
    Applicant: TRANSFERT PLUS
    Inventors: Richard Béliveau, Michel Demeule, Yanick Bertrand, Jonathan Michaud-Levesque, Yannève Rolland, Julie Jodoin
  • Compound and method for regulating plasminogen activation and cell migration
    Patent number: 7919103
    Abstract: The invention relates to novel regulators of plasminogen activation and their use for regulating cell migration, plasminolysis, angiogenesis, fibrinolysis, for treating cancer and thrombo-embolic diseases such as heart stroke. Furthermore, the present invention relates to novel pharmaceutical compositions form regulating cell migration, plasminolysis, angiogenesis and for treating cancer. In particular, the present invention relates to a method of regulating the activation of plasminogen comprising contacting a solution of pro-urokinase (uPA) or tissue plasminogen activator (tPA) and plasminogen with melanotransferrin (p97) for a time sufficient to effect regulation thereof.
    Type: Grant
    Filed: May 7, 2004
    Date of Patent: April 5, 2011
    Assignee: Transfert Plus
    Inventors: Richard Béliveau, Michel Demeule, Yanick Bertrand, Jonathan Michaud-Levesque, Yannève Rolland, Julie Jodoin
  • Compound and method for regulating plasminogen activation and cell migration
    Publication number: 20070053894
    Abstract: The invention relates to novel regulators of plasminogen activation and their use for regulating cell migration, plasminolysis, angiogenesis, fibrinolysis, for treating cancer and thrombo-embolic diseases such as heart stroke. Furthermore, the present invention relates to novel pharmaceutical compositions form regulating cell migration, plasminolysis, angiogenesis and for treating cancer. In particular, the present invention relates to a method of regulating the activation of plasminogen comprising contacting a solution of pro-urokinase (uPA) or tissue plasminogen activator (tPA) and plasminogen with melanotransferrin (p97) for a time sufficient to effect regulation thereof.
    Type: Application
    Filed: May 7, 2004
    Publication date: March 8, 2007
    Applicant: TRANSFERT PLUS
    Inventors: Richard Beliveau, Michel Demeule, Yanick Bertrand, Jonathan Michaud-Levesque, Yanneve Rolland, Julie Jodoin